Approval · Notice of Compliance 30106 · 2023
RAYALDEE: Notice of Compliance 30106
Issued February 9, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30106
- Date
- February 9, 2023
- Company
- Eirgen Pharma LimitedWaterford, --, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAYALDEE | 02478498 | Approved |
Medicinal ingredients
- CALCIFEDIOL 30 MCG per CAP